Theravance (THRX +4.8%) draws some notice from investors after Sanford Bernstein initiates...
Theravance (THRX +4.8%) draws some notice from investors after Sanford Bernstein initiates coverage with an Outperform rating on shares. According to a SEC filing, the biopharmaceutical company also saw some insider buying recently.
Are you Bullish or Bearish on ?
Results for ()
Thanks for sharing your thoughts.
From other sites
at Zacks.com (Wed, 8:35AM)
at Nasdaq.com (Feb 9, 2015)
at Nasdaq.com (Jan 23, 2015)
at CNBC.com (Jun 11, 2014)
at Fox Business (Feb 20, 2014)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs